Esperion Therapeutics, Inc.
ESPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$52 | -$209 | -$234 | -$269 |
| Dep. & Amort. | $0 | $0 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12 | $12 | $15 | $24 |
| Change in WC | -$61 | $14 | -$3 | -$53 |
| Other Non-Cash | $77 | $48 | $46 | $33 |
| Operating Cash Flow | -$24 | -$135 | -$175 | -$264 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$60 | -$50 |
| Inv. Sales/Matur. | $0 | $43 | $68 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | $43 | $8 | -$50 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $35 | $0 | $0 | -$0 |
| Stock Issued | $91 | $57 | $91 | $219 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$40 | -$6 | -$58 | $50 |
| Financing Cash Flow | $86 | $50 | $33 | $268 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $63 | -$43 | -$134 | -$46 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82 | $125 | $259 | $305 |
| End Cash | $145 | $82 | $125 | $259 |
| Free Cash Flow | -$24 | -$135 | -$175 | -$264 |